Related Articles |
Granulocyte transfusions in patients with chronic granulomatous disease and refractory infections: the NIH experience.
J Allergy Clin Immunol. 2017 Mar 22;:
Authors: Marciano BE, Allen ES, Cantilena CC, Kristosturyan E, Klein HG, Fleisher TA, Holland SM, Malech HL, Rosenzweig SD
Abstract
Granulocyte transfusions are a relatively safe adjunctive therapeutic option for patients with chronic granulomatous disease and severe/refractory bacterial or fungal infections. Early initiation, high frequency and sustained therapy is associated with significantly better outcomes.
PMID: 28342916 [PubMed – as supplied by publisher]
Powered by WPeMatico